Prosecution Insights
Prosecution Insights
Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
Eustralis Pharmaceuticals Limited (Trading AS Pressura Neuro) is currently managing 1 pending office action. This activity occurs within the Biotechnology & Pharmaceuticals technology area, which dictates the scientific expertise required for the case. The prosecution is concentrated in 1 distinct art unit, suggesting that the technical subject matter is specialized. With 1 distinct examiner assigned, the applicant can maintain a consistent communication channel with the USPTO.
The busiest examiner, TRAN, ERIC, is currently overseeing 1 pending office action. Because this 1 pending office action is the current focus of the portfolio, the applicant's success depends on addressing the specific concerns of this examiner. The 1 distinct art unit involved indicates that the prosecution does not face the challenge of differing procedural interpretations from various office branches.
Practitioners should focus on the specific examination history of TRAN, ERIC to prepare for the 1 pending office action. The Biotechnology & Pharmaceuticals technology area requires a deep understanding of relevant precedents and technical standards. By operating within 1 distinct art unit, the company can streamline its internal documentation and response strategies. This centralized structure, featuring 1 distinct examiner, allows for a predictable prosecution timeline.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| No statute on record | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| TRAN, ERIC | 1 | 70.8% | +23.3% |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17640864 | Therapeutic Methods And Uses Thereof | TRAN, ERIC | 56d |
| Art Unit | Apps |
|---|---|
| 1629 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 17640864 | Therapeutic Methods And Uses Thereof | TRAN, ERIC | 1629 | Other | Non-Final OA | 56d | Pending | Mar 07, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial